{"id":42086,"date":"2018-02-22T16:22:47","date_gmt":"2018-02-22T14:22:47","guid":{"rendered":"https:\/\/newserver.fyb.de\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/"},"modified":"2018-02-22T16:22:47","modified_gmt":"2018-02-22T14:22:47","slug":"dla-piper-advises-evers-sale-to-bright-future-pharma-labs","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/","title":{"rendered":"DLA Piper advises Evers sale to Bright Future Pharma Labs"},"content":{"rendered":"<p>Pinnen\u00adberg \u2014 The phar\u00admaceu\u00adti\u00adcal factory<strong> Evers<\/strong> GmbH &amp; Co KG sells to the Chinese company <strong>Bright Future Phar\u00admaceu\u00adti\u00adcal Labo\u00adra\u00adto\u00adries<\/strong> Ltd. The company produ\u00adces mainly natu\u00adral medi\u00adci\u00adnes for the urology and gastro\u00aden\u00adte\u00adro\u00adlogy sector, which are sold inter\u00adna\u00adtio\u00adnally and very stron\u00adgly on the Asian market, espe\u00adci\u00adally in Japan and China. The parties have agreed not to disc\u00adlose the purchase price.<\/p>\n<p>The family busi\u00adness Phar\u00adma\u00adzeu\u00adti\u00adsche Fabrik Evers GmbH &amp; Co KG was foun\u00added in 1933. Head\u00adquar\u00adte\u00adred in Pinne\u00adberg, near Hamburg, Germany, the company focu\u00adses on a selec\u00adted range of natu\u00adral medi\u00adci\u00adnes for the urology and gastro\u00aden\u00adte\u00adro\u00adlogy sectors and acts as a licen\u00adsor in seve\u00adral count\u00adries. The Evipro\u00adstat S, Evipro\u00adstat N and Gallith brands are among the estab\u00adlished products in this&nbsp;field.<\/p>\n<p>Estab\u00adlished in 1993, Bright Future Phar\u00admaceu\u00adti\u00adcal Labo\u00adra\u00adto\u00adries Ltd is the largest GMP (Good Manu\u00adfac\u00adtu\u00adring Prac\u00adtice) certi\u00adfied phar\u00admaceu\u00adti\u00adcal manu\u00adfac\u00adtu\u00adrer in Hong Kong. The company, with more than 7,000 employees, provi\u00addes people with access to medi\u00adci\u00adnes at afforda\u00adble prices and is parti\u00adcu\u00adlarly active in key growth markets such as Hong Kong, main\u00adland China, North America, Africa, Southe\u00adast Asia and Europe.<\/p>\n<p><strong>Advi\u00adsors to Evers GmbH &amp; Co KG: DLA&nbsp;Piper<\/strong><br>\nThe tran\u00adsac\u00adtion once again under\u00adlines the exten\u00adsive expe\u00adri\u00adence of the DLA Piper German China Desk, this time on the German seller side.<\/p>\n<p>The core team of DLA Piper under the leader\u00adship of part\u00adner <strong>Dr. Nils Krause (photo<\/strong> ) contin\u00adued to consist of senior asso\u00adciate Dr. Jan-Phil\u00adipp Meier and asso\u00adcia\u00adtes Dr. Jasper von Georg and Ronja Hecker (all Corpo\u00adrate, Hamburg). In addi\u00adtion, Part\u00adner Guido Kleve, Coun\u00adsel Dr. Thilo Streit (both Liti\u00adga\u00adtion and Regu\u00adla\u00adtory, Colo\u00adgne) and Chris\u00adtian Lonquich (Real Estate, Frank\u00adfurt) as well as Tran\u00adsac\u00adtion Lawyer Hui Hao (Corpo\u00adrate, Hamburg) were part of the&nbsp;team.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pinnen\u00adberg \u2014 The phar\u00admaceu\u00adti\u00adcal factory Evers GmbH &amp; Co KG sells to the Chinese company Bright Future Phar\u00admaceu\u00adti\u00adcal Labo\u00adra\u00adto\u00adries Ltd. The company produ\u00adces mainly natu\u00adral medi\u00adci\u00adnes for the urology and gastro\u00aden\u00adte\u00adro\u00adlogy sector, which are sold inter\u00adna\u00adtio\u00adnally and very stron\u00adgly on the Asian market, espe\u00adci\u00adally in Japan and China. The parties have agreed not to disclose&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42095,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366],"tags":[],"class_list":["post-42086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","news-category-deals-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Pinnen\u00adberg \u2014 The phar\u00admaceu\u00adti\u00adcal factory Evers GmbH &amp; Co KG sells to the Chinese company Bright Future Phar\u00admaceu\u00adti\u00adcal Labo\u00adra\u00adto\u00adries Ltd. The company produ\u00adces mainly natu\u00adral medi\u00adci\u00adnes for the urology and gastro\u00aden\u00adte\u00adro\u00adlogy sector, which are sold inter\u00adna\u00adtio\u00adnally and very stron\u00adgly on the Asian market, espe\u00adci\u00adally in Japan and China. The parties have agreed not to disc\u00adlose [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-22T14:22:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"220\" \/>\n\t<meta property=\"og:image:height\" content=\"227\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"DLA Piper advises Evers sale to Bright Future Pharma Labs\",\"datePublished\":\"2018-02-22T14:22:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\"},\"wordCount\":284,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\",\"url\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\",\"name\":\"DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg\",\"datePublished\":\"2018-02-22T14:22:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg\",\"width\":220,\"height\":227},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DLA Piper advises Evers sale to Bright Future Pharma Labs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/","og_locale":"en_US","og_type":"article","og_title":"DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook","og_description":"Pinnen\u00adberg \u2014 The phar\u00admaceu\u00adti\u00adcal factory Evers GmbH &amp; Co KG sells to the Chinese company Bright Future Phar\u00admaceu\u00adti\u00adcal Labo\u00adra\u00adto\u00adries Ltd. The company produ\u00adces mainly natu\u00adral medi\u00adci\u00adnes for the urology and gastro\u00aden\u00adte\u00adro\u00adlogy sector, which are sold inter\u00adna\u00adtio\u00adnally and very stron\u00adgly on the Asian market, espe\u00adci\u00adally in Japan and China. The parties have agreed not to disc\u00adlose [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2018-02-22T14:22:47+00:00","og_image":[{"width":220,"height":227,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"DLA Piper advises Evers sale to Bright Future Pharma Labs","datePublished":"2018-02-22T14:22:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/"},"wordCount":284,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg","articleSection":["General","Featured","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/","url":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/","name":"DLA Piper advises Evers sale to Bright Future Pharma Labs - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg","datePublished":"2018-02-22T14:22:47+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/02\/a-krause.jpg","width":220,"height":227},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/dla-piper-advises-evers-sale-to-bright-future-pharma-labs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"DLA Piper advises Evers sale to Bright Future Pharma Labs"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42086"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42086\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42095"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}